Monica Paci
Overview
Explore the profile of Monica Paci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Privato R, Pezzoli F, Barni S, Renzo S, Paci M, Barp J, et al.
J Pediatr Gastroenterol Nutr
. 2024 Nov;
80(1):57-68.
PMID: 39543959
Objectives: We aimed to analyze the episodes of esophageal food bolus impaction (EFI) occurred over a time of 15 years in children admitted to a large pediatric emergency department (PED),...
2.
Scarallo L, Banci E, De Blasi A, Paci M, Renzo S, Naldini S, et al.
J Pediatr Gastroenterol Nutr
. 2024 Jul;
79(3):592-601.
PMID: 38962891
Objectives: We aimed to appraise the real-life efficacy of Crohn's disease exclusion diet (CDED) coupled with partial enteral nutrition (PEN) in inducing clinical and biochemical remission at disease onset and...
3.
Barni S, Pessina B, Scarallo L, Renzo S, Pieri E, Labriola F, et al.
Clin Exp Allergy
. 2024 Jan;
54(3):225-227.
PMID: 38262705
No abstract available.
4.
Histological healing as a predictor of sustained clinical remission in paediatric ulcerative colitis
Scarallo L, Fioretti L, Paci M, Naldini S, Renzo S, Barp J, et al.
Dig Liver Dis
. 2023 Jul;
56(1):43-49.
PMID: 37455156
Background: The study aimed to assess the longitudinal impact of endoscopic healing (EH) and histological healing (HH) in a cohort of paediatric patients affected by ulcerative colitis (UC). Methods: This...
5.
Pugnetti L, Curci D, Bidoli C, Gerdol M, Celsi F, Renzo S, et al.
Biomed Pharmacother
. 2023 May;
164:114927.
PMID: 37257228
Thalidomide has emerged as an effective immunomodulator in the treatment of pediatric patients with inflammatory bowel disease (IBD) refractory to standard therapies. Cereblon (CRBN), a component of E3 protein ligase...
6.
Casari S, Di Paola M, Banci E, Diallo S, Scarallo L, Renzo S, et al.
Nutrients
. 2022 May;
14(9).
PMID: 35565752
(1) Background: Sub-Saharan Africa is experiencing the fastest urbanization worldwide. People in rural areas still have a traditional and rural lifestyle, whereas the Westernization of diet and lifestyle is already...
7.
Rubino C, Monacelli C, Marrani E, Paci M, Indolfi G, Simonini G, et al.
Clin Rheumatol
. 2021 Jul;
40(12):5041-5046.
PMID: 34273001
Introduction And Objectives: Immunoglobulin A vasculitis (IgAV), the most common childhood vasculitis, is associated with gastrointestinal (GI) involvement in 50-75% of cases. The aim of this study was to describe...
8.
Scarallo L, Bolasco G, Barp J, Bianconi M, Di Paola M, di Toma M, et al.
Inflamm Bowel Dis
. 2021 Apr;
28(2):183-191.
PMID: 33835155
Background: The aim of the present study was to investigate outcomes of anti-TNF-alpha (ATA) withdrawal in selected pediatric patients with inflammatory bowel disease who achieved clinical remission and mucosal and...
9.
Norsa L, Ferrari A, Arrigo S, Bramuzzo M, Saccomani M, Di Nardo G, et al.
J Pediatr Gastroenterol Nutr
. 2021 Mar;
73(1):48-53.
PMID: 33720096
Objectives And Study: There is a large interobserver variability in evaluating mucosal lesions of inflammatory bowel disease (IBD), especially in pediatric patients. This multicenter prospective observational study aims to evaluate...
10.
Scarallo L, Alvisi P, Bolasco G, di Toma M, Lanari M, Cangiari A, et al.
J Pediatr Gastroenterol Nutr
. 2021 Jan;
72(5):728-735.
PMID: 33399329
Objectives: Mucosal healing (MH) and histological healing (HH) have been recently proposed as a novel treatment target for inflammatory bowel disease (IBD). The aim of the present study was to...